Group 1 - The company, Shanghai Nanmo Biotechnology Co., Ltd., announced that its wholly-owned subsidiary, Shanghai Dishi Biotechnology Co., Ltd., has signed a contract with the Shanghai Jinshan District Science and Technology Commission to receive a government subsidy of 5.8 million yuan [1] - The government subsidy consists of two parts: 2.9 million yuan related to assets, accounting for 0.15% of the company's total audited assets for the most recent fiscal year, and 2.9 million yuan related to income, which represents 44.65% of the company's audited net profit for the same period [1] - As of the announcement date, the subsidy funds have not yet been received, and the company will account for the subsidy according to the relevant accounting standards upon receipt [1] Group 2 - The company emphasizes that the recognition and classification of the government subsidy will be subject to the final results of the annual audit, and investors are advised to be aware of investment risks [1]
上海南方模式生物科技股份有限公司 关于子公司获得政府补助的公告